Intrinsic Medicine Seeks U.S. IPO For IBS Treatments
Intrinsic Medicine has filed to raise investment via IPO. The firm is developing treatments for irritable bowel syndrome variants. Read more on INRX stock here.
United States Grand View Evelo Biosciences Alexander Martinez European Patent Office Company Technology
Source: seekingalpha.com